HBM Healthcare Investments

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

HBM is also committed to Human Rights and decent working conditions in its supply chain. An audit programme based on SA8000 is applied to all significant suppliers located in lower cost manufacturing areas in order to provide assurance in this respect.

HBM rely on the perfectly matched components of the complete measurement chain that guarantees maximum accuracy of measurement results and enables optimization of the complete product life cycle: from the development through the testing stages, as well as in manufacturing and production.

HBM Healthcare Investments has been awarded the Alpha,Blue Chip and Prime Award by the Alternative Investment Market. They have also been named by Forbes Magazine as one of the 10 most promising companies to invest in the healthcare space.